Molecular biomarkers capable of predicting recurrence patterns and prognosis are helpful for risk stratification and providing appropriate treatment to patients with hepatocellular carcinoma (HCC). | Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma